EUVIMEDEUVIMED entdecken
Open Access

Where are we going with CML research?

D Perrotti

Leukemia Supplements · 2012

DOI: 10.1038/leusup.2012.26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia Supplements, 2012. Verfasst von D Perrotti. Beteiligte Einrichtung: Department of Microbiology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University , Columbus, OH, USA. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BCR-ABL1FTY720Janus kinase 2chronic myelogenous leukemialeukemic hematopoietic stem cellsprotein phosphatase 2A

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University , Columbus, OH, USA.

Zitieren

APA

Perrotti, D. (2012). Where are we going with CML research?. Leukemia Supplements. https://doi.org/10.1038/leusup.2012.26

Vancouver

Perrotti D. Where are we going with CML research?. Leukemia Supplements. 2012. doi:10.1038/leusup.2012.26

BibTeX
@article{Perrotti2012,
  author = {Perrotti, D},
  title = {Where are we going with CML research?},
  journal = {Leukemia Supplements},
  year = {2012},
  doi = {10.1038/leusup.2012.26}
}
Kostenlos starten →